# Anika Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Nov 21, 2025

- Company: [Anika Therapeutics, Inc.](/companies/anik.md) (CIK 898437)
- Form: SCHEDULE 13D/A
- Filed: 2025-11-21
- Accepted by EDGAR: Nov 21, 2025, 09:21 ET
- Period: not reported
- Accession: 0000902664-25-005133
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/898437/000090266425005133/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/898437/000090266425005133/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/898437/000090266425005133/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Nov 21, 2025.
Source: SEC EDGAR, the filing index for accession 0000902664-25-005133. Last ingested by Listed: Oct 24, 2026, 15:00 ET. No prices; not investment advice.